secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001493152-23-045030
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics shareholders approve 84x increase in authorized shares to 350M and expansion of equity plan
--------------------------------------------------------------------------------

- Authorized common shares increased from 4,166,666 to 350,000,000 (84x).
- Equity plan shares increased from 166,667 to 1,166,667 (7x) for future awards.
- All seven director nominees re-elected; Cherry Bekaert LLP ratified as auditor.
- Non-binding advisory vote on exec compensation passed (794,152 for, 105,633 against).
- Series F convertible preferred stock issuance also approved (834,513 for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315223045030/0001493152-23-045030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315223045030/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-045030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer